A new cost analysis finds that matching relapsed lymphoma treatment to a personalized drug-response test was associated with longer disease control and a lower estimated daily treatment cost in dogs.
|Articles|January 4, 2011
Today's Daily Dose: Cancer pain
A novel form of pain relief for canine osteosarcoma.
Advertisement
Untitled Document
“Pamidronate provides a novel method of pain relief in dogs with osteosarcoma. It can be safely combined with other methods of pain relief such as radiation therapy for more effective pain control.”
Advertisement
Advertisement
Related to this article
A pain management protocol is only as good as the conversation behind it.
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Preclinical testing at The Ohio State University found Telomir-Zn inhibited the growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in vivo study in dogs with naturally occurring tumors.
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Advertisement
Advertisement
Trending on dvm360
1
AAVMC and Chewy Health open nominations for 2027 veterinary student leadership scholarships
2
Saline injection lot recalled after potassium chloride bag found in mislabeled wrap
3
FAQs: Rising rabies exposure calls put PEP decisions back in focus
4
Pet Poison Helpline reports rise in Apoquel calls
5